Structure-Activity Relationship Studies of HIV-1 Integrase Oligonucleotide Inhibitors. 2011

Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
Department of Chemistry, Lomonosov Moscow State University , Leninskie gory 1-3, 119991 Moscow, Russia.

Integration of human immunodeficiency virus type 1 DNA into an infected cell genome is one of the key steps of the viral replication cycle. Therefore, viral enzyme integrase, which realizes the integration, represents an attractive and validated target for the development of new antiviral drugs. In this paper, the anti-integrase activity of a series of conjugates of single-stranded oligonucleotides with hydrophobic molecules was tested, and the structure-activity relationships were also analyzed. Both oligonucleotide and hydrophobic parts of the conjugates influenced the inhibitory potency. Conjugates of 11-mer phosphorothioate oligonucleotides with 6-carboxy-4,7,2',4',5',7'-hexachlorofluorescein (HEX) were found to be the most efficient inhibitors (IC50 = 20 nM) and might be considered as lead compounds for further development of integrase inhibitors.

UI MeSH Term Description Entries

Related Publications

Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
February 2006, ChemMedChem,
Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
September 2010, Bioorganic & medicinal chemistry,
Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
January 2007, European journal of medicinal chemistry,
Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
January 2021, Iranian journal of pharmaceutical research : IJPR,
Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
June 2010, Molecules (Basel, Switzerland),
Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
April 2009, Bioorganic & medicinal chemistry,
Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
September 2003, Current medicinal chemistry,
Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
April 2010, Molecules (Basel, Switzerland),
Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
October 2012, Journal of enzyme inhibition and medicinal chemistry,
Julia Agapkina, and Timofei Zatsepin, and Ekaterina Knyazhanskaya, and Jean-Francois Mouscadet, and Marina Gottikh
December 2006, European journal of medicinal chemistry,
Copied contents to your clipboard!